|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Biophysical factors have been implicated in the development of pulmonary ischemia-reperfusion injury. In isolated rabbit lungs, the impact of vascular and alveolar distension, with and without alveolar oxygen supply, was investigated. With interruption of both perfusion (zero intravascular pressure) and ventilation, reperfusion after 120 min of warm ischemia resulted in transient pulmonary hypertension, with largely unchanged microvascular pressures, followed by a dramatic leakage response with ~ 10-fold increased capillary filtration coefficients (Kfc) and severe edema. Maintenance of vascular distension during ischemia (intravascular pressure of ~ 2 to 3 mm Hg) reduced the hypertension and fully suppressed the leakage. Employing ischemic periods of 180 and 240 min, ventilation of the lungs with 21 or 100% oxygen > ventilation with nitrogen during perfusion stop, but not static anoxic inflation, further enhanced the protective effect of vascular distension. At optimal biophysical support (vascular distension and ongoing normoxic ventilation), even 240 min of warm ischemia was tolerated with only moderate Kfc increase. We conclude that biophysical factors exert marked influence on pulmonary ischemia-reperfusion injury. Maintenance of vascular distension possesses strong protective potency, further enhanced by continued ventilation and alveolar oxygen supply during ischemia. These results may have important implications for organ preservation in lung transplantation.
| |
INTRODUCTION |
|---|
|
|
|---|
Ischemia-reperfusion (I-R) lung injury plays a significant role in clinical situations such as lung transplantation (1), pulmonary thromboendarterectomy (2), reexpansion of collapsed lungs (3), and fibrinolysis after lung embolism (4). Lung failure associated with I-R is characterized by increased microvascular permeability and pulmonary vascular resistance with subsequent edema formation and impairment of gas exchange. Interestingly, the development of this syndrome is significantly influenced by variables of ventilation during lung ischemia: as a special feature of the lung, oxygen supply to pulmonary tissues can ensue from both the intravascular and the alveolar space. As a consequence, pulmonary ischemia does not necessarily result in hypoxia of the whole organ when ventilation is maintained, which may be followed by attenuation of I-R. On the other hand, alveolar oxygen represents a cofactor for the generation of free radicals, and continuous oxygen supply might thus enhance I-R injury. Against this background, lung models addressing mechanisms of I-R injury are difficult to compare. In previous studies, ischemia was induced while ventilation was stopped, with lungs being inflated (5) as well as deflated (8, 9). In other investigations with ongoing ventilation during ischemia, the role of alveolar oxygen tension was controversial: In some studies, I-R injury as found to increase in dependency on alveolar oxygen during ischemia (10), whereas other studies provided evidence for a protective (13) or missing effect of oxygen (14, 15). In addition, the alveolar distension per se as mediated by ventilation or inflation, independent of oxygen supply, may be important for the prevention of lung reperfusion injury. Several early studies reported a significant benefit of lung inflation during preservation for transplantation (16). More recent investigations have demonstrated that maintenance of ventilation during ischemia may decrease injury in vivo (13) and in ex vivo perfused-lung models (15, 19). These results suggest a significant role of biophysical factors in I-R lung injury.
Mechanical effects on the lung microvasculature may, however, not only be transferred via alveolar distension but also
via vascular distension. In pulmonary artery endothelial monolayers, the establishment of a positive baseline hydrostatic pressure results in an impressive "sealing" of the monolayer, i.e., a
reduction of hydraulic conductivity and a decrease in protein
permeability (20). Moreover, pilot experiments performed
when establishing the ischemia/reperfusion model in the rabbit lungs signaled that the baseline intravascular (hydrostatic)
pressure during ischemia was to be considered as an independent and possibly important variable. The current study was
thus designed to address this issue and to analyze the impact
of vascular and alveolar distension, with and without oxygen
supply during ischemia, on lung I-R injury. We employed warm
ischemia in isolated perfused rabbit lungs as this model permits independent manipulation of perfusion and ventilation parameters over a wide range without invoking systemic influences, and it allows differentiation of hydrostatic and permeability factors contributing to lung edema. When applying a
positive intravascular pressure, its height corresponded to that
of the lung microvascular pressure under conditions of pulsatile flow (
4 mm Hg, slowly declining during the ischemic period). Noteworthy, we found that significant protection
against I-R-induced microvascular leakage can be conferred
by (1) continued ventilation, (2) presence of alveolar oxygen
and, most strikingly, (3) maintenance of a positive intravascular pressure during lung ischemia. The finding of a crucial role
of vascular distension versus collapse for the development of
reperfusion injury may have major implication for preservation strategies in organ transplantation.
| |
METHODS |
|---|
|
|
|---|
Reagents
Sterile Krebs-Henseleit hydroxyethylamylopectine buffer (KHHB) was obtained from Serag-Wiessner (Naila, Germany). The buffer contained 120 mM NaCl, 4.3 mM KCl, 1.1 mM KH2PO4, 24 mM NaHCO3, 2.4 mM CaCl2, 1.3 mM MgPO4, and 2.4 g/L glucose, as well as 5% (wt/ vol) hydroxyethylamylopectine (MW, 200,000) as oncotic agent. Gas mixtures for ventilation containing 21%O2/5%CO2/79%N2, 95%O2/ 5%CO2, or 95%N2/5%CO2 were obtained from Messer Griesheim (Herborn, Germany).
Lung Model
The technique of isolated rabbit lung perfusion has been described in previous investigations (overview in reference 21). Briefly, rabbits of either sex weighing 2.6 to 2.9 kg were anticoagulated with heparin and deeply anesthetized with a mixture of ketamine and xylazine. Tracheostomy was performed, and the animals were ventilated with room air, using a Harvard respirator (tidal volume, 30 ml; frequency, 30 breaths/ min; positive end-expiratory pressure, 1 cm H2O [Hugo Sachs Elektronik, March-Hugstetten, Germany]). After midsternal thoracotomy, catheters were placed into the pulmonary artery and the left atrium, and perfusion with sterile KHHB was started. Sterilized perfusion circuit tubing was used throughout. In parallel with the onset of artificial perfusion, room air ventilation was changed to a gas mixture containing 21% O2 and 5% CO2, with a balance of N2. After extensive rinsing of the lung vasculature, the lungs were recirculatingly perfused with a constant pulsatile flow of 100 ml/min (total recirculating volume, 300 ml). Left atrial pressure was set at 2 mm Hg (referenced at the hilus), and the whole perfusion system was equilibrated at 37° C. Additionally, the inspiration loop of the ventilation system was connected to a humidifier and heated at 37° C by a thermostat. Lungs were placed in a humidified, warmed chamber to avoid desiccation and suspended from a force transducer for continuous registration of organ weight.
The capillary filtration coefficient (Kfc) and the total vascular compliance were determined gravimetrically from the slope of the lung weight gain curve induced by a 7.5-mm Hg step elevation of the venous pressure for 8 min. The application of this method to the present model and the use of time zero extrapolation of the slope of weight gain for the calculation of Kfc have been described in detail (22). Lung weight gain was calculated as the difference in organ weight measured directly before and 5 min after each of these pressure elevation maneuvers. Vascular compliance was calculated from the initial steep increase in lung weight upon step change in microvascular pressure. Pulmonary arterial and venous pressures were monitored by pressure transducers. The microvascular pressure (Ppc) was determined by the arterial and venous double occlusion technique. Occlusion maneuvers were performed in end-expiration by means of electromagnetic tube-clamping devices, synchronized by a D/A-A/D converter connected to a personal computer. This converter allowed parallel data collection at a rate of 20 Hz, which was processed by a spread-sheet program (Microsoft ExcelTM) for calculation of microvascular pressures.
Lungs included in the study (1) had a homogeneous white appearance with no signs of hemostasis, edema, or atelectasis; (2) had initial pulmonary artery and ventilation pressures in the normal range; and (3) were isogravimetric during an initial steady-state period of at least 30 min.
Experimental Protocols
After termination of the initial steady-state period and performance of a control hydrostatic challenge, time was set at zero, and lungs were exposed to ischemia by stopping the perfusion. In the course of the ischemic period, interventions were performed according to one of the following protocols. A total of 98 lungs was investigated.
FIO2 = 0.21/IP+/vent. Lungs were exposed to normoxic ventilation during 60, 120, 180 and 240 min of ischemia. Upon stopping the perfusion, the arterial and venous catheters were both clamped for maintenance of a positive intravascular pressure (IP+) during ischemia.
FIO2 = 0.21/IP
/vent. Lungs were exposed to normoxic ventilation
during different periods of ischemia. In these experiments, clamping
of the arterial and venous catheter was omitted, resulting in an intravascular pressure of zero (IP
) during ischemia.
FIO2 = 0/IP+/vent. Lungs were exposed to anoxic ventilation during different periods of ischemia, and a positive intravascular pressure (IP+) during ischemia was maintained.
FIO2 = 0/IP
/vent. Lungs were exposed to anoxic ventilation during different periods of ischemia. Clamping of the arterial and venous
catheter was omitted, resulting in an intravascular pressure of zero
(IP
) during ischemia.
FIO2 = 0/IP+/collapse. Lungs were deflated during different periods of ischemia after the remaining dead-space oxygen had been washed out by short-time ventilation with an oxygen-free gas mixture (95% N2, 5% CO2). Upon stopping the perfusion, a positive intravascular pressure (IP+) was maintained.
FIO2 = 0/IP+/static. Lungs were statically inflated during 180 min of ischemia after remaining dead-space oxygen had been washed out by short-time ventilation with an oxygen-free gas mixture (95% N2, 5% CO2). The inflation pressure was maintained at 6 mm Hg because this pressure level corresponds to the normal mean ventilation pressure in the isolated lung model. A positive intravascular pressure (IP+) during ischemia was again maintained by clamping of the arterial and venous catheter.
FIO2 = 0.95/IP+/vent. Lungs were exposed to hyperoxic ventilation for 180 min of ischemia, and a positive intravascular pressure (IP+) during ischemia was maintained.
Each group encompassed four to seven independent experiments (Table 1).
|
At the end of ischemia, ventilation was restored or changed to normoxia (FIO2 = 0.21), respectively (except the FIO2 = 0.95/IP+/vent lungs, which were ventilated with 95% oxygen even during reperfusion), and perfusion was reestablished with gradual increase in flow over 30 s. Hydrostatic challenges were performed at 30, 60, and 90 min after onset of reperfusion. Double occlusion maneuvers (8 s each) for assessment of microvascular pressure were performed before ischemia as well as 3, 30, 60, and 90 min after reperfusion.
Control lungs were perfused and ventilated (FIO2 = 0.21) without interruption of flow, and Kfc as well as microvascular pressure measurements were undertaken at time points corresponding to the ischemia experiments.
Data Analysis
Data were expressed as mean ± SEM. Differences were analyzed by analysis of variance; p values of less than 0.05 were considered to represent a significant difference.
| |
RESULTS |
|---|
|
|
|---|
Pulmonary Arterial Pressure
In control experiments, pulmonary arterial pressures were
constant throughout the entire experimental period. After 60 min of ischemia, all lungs with an intravascular pressure of
zero (IP
) during ischemia displayed a significant Ppa increase upon reperfusion (Figure 1). Only minor Ppa changes
were noted in response to 60 min of ischemia when the intravascular pressure was maintained positive (IP+). When the
ischemic period was extended to 120 min, the pressor response
in IP
lungs was even more prominent (approximately doubling of baseline pressure), whereas in IP+ lungs again a significant attenuation of the Ppa increase was noted. These effects
were independent of the presence or absence of alveolar oxygen during ischemia. After 180 min of ischemia, which was
only performed in IP+ lungs, all experimental conditions with
alveolar oxygen absent resulted in a more impressive rise of
Ppa than those with alveolar oxygen present during ischemia
(Figure 2). No difference was noted between FIO2 = 0.21 and
FIO2 = 0.95. After 240 min of ischemia, again performed only
in IP+ lungs, the Ppa increased similarly under both normoxic
and anoxic conditions. The maximal Ppa rise was, however,
lower than in the lungs with 120 min ischemia under IP
conditions.
|
|
Microvascular Pressure and Vascular Compliance
In control lungs, microvascular pressures did not change during the entire experimental time period (Table 1). Similarly, microvascular pressures were largely constant in all ischemic lungs, with pressure changes never surpassing 2 mm Hg after reperfusion as compared with preischemic values (Table 1). No significant changes between the different experimental groups were noted. These data indicate that changes in hydrostatic forces may only negligibly contribute to any enhancement of capillary filtration and edema formation in the course of reperfusion. Values of vascular compliance did not differ between control lungs and the different experimental groups, and they did not significantly change in the reperfusion period as compared with the preischemic period (data not given in detail).
Kfc and Weight Gain
After 60 min of ischemia, lungs with a positive intravascular
pressure during ischemia displayed identical Kfc values as
compared with nonischemic lungs. In IP
lungs, a slight tendency toward increased permeability was observed (Figure 3,
and Table 1). As obvious in Table 1, the intravascular pressure
measured at the end of ischemia in the IP+ lungs slowly
dropped with the duration of the ischemic period, but it was
still in the range of 1 to 2 mm Hg even after 240 min.
|
After 120 min of ischemia, these differences became striking: Kfc values dramatically increased in IP
lungs as compared
with the corresponding IP+ experiments, which was accompanied by severe edema formation. This effect was observed in
both normoxic and anoxic ventilated lungs. Within the group
of IP+ lungs, organs maintained in the absence of alveolar oxygen during the 120-min period of ischemia displayed a slight
tendency for Kfc increase as compared with the control lungs
and the lungs ventilated with normoxic gas.
After 180 min of ischemia, lungs rendered anoxic by deflation, nitrogen ventilation, or static inflation all showed markedly increased microvascular permeability (Figure 4), accompanied by a weight increase of corresponding severity. This leakage response was, however, significantly less prominent in lungs being continuously ventilated with nitrogen during ischemia, as compared with alveolar collapse or static inflation with anoxic gas. These findings indicate protective effects by (1) oxygen and (2) oxygen-independent ventilatory movements in IP+ lungs. Lungs ventilated with either 21 or 95% oxygen during ischemia did not differ from control lungs in terms of Kfc or organ weight.
|
When lungs were rendered ischemic for 240 min, the Kfc rise in FIO2 = 0 organs was further enhanced, even in the presence of continued ventilation during ischemia. Under the "optimal" regimen characterized in this study, i.e., positive intravascular pressure and permanent ventilation with normoxic gas during the ischemic period, even the 240 min ischemia provocation caused only some intermediate Kfc increase and edema formation.
| |
DISCUSSION |
|---|
|
|
|---|
The present study centers on the impact of biophysical factors on the pathogenesis of lung injury in a well reproducible model of warm ischemia and reperfusion. As compared with the routine approach with interruption of perfusion and ventilation, both continuous alveolar oxygen supply during ischemia and ventilatory movements of the alveolar compartment during this period were noted to attenuate the leakage response upon reperfusion. The most impressive reduction of lung injury was, however, achieved by vascular distension through maintenance of a small positive intravascular pressure during the period of ischemia. This finding may be of interest for both the understanding of the pathogenetic events in ischemia/reperfusion and the development of organ protective strategies in lung transplantation.
As anticipated, warm I-R provoked a transient increase in Ppa upon onset of reperfusion. The pressure elevation peaked within the first few minutes after reestablishment of perfusion. It never surpassed 12 mm Hg with rapid subsequent decline of Ppa, and the nearly unchanged values of microvascular pressure reflect that it is mostly due to a transient increase in precapillary vascular resistance. Previous studies concerned with warm ischemia in rabbit lungs suggested that thromboxane is a major contributor to this initial hypertensive response (23). Although prostanoid generation was not assessed in the present study, experiments with the thromboxane receptor antagonist BM 13505, which suppressed the Ppa increase upon reperfusion by > 70% (data not given), support this notion. Several lines of evidence do, however, clearly demonstrate that the transient pressure elevation is not the driving force for the subsequent development of the capillary leakage response: (1) when the postischemic Kfc values were assessed (30 min after onset of reperfusion), the Ppa increase returned to near baseline levels in the majority of experiments; (2) the microvascular pressure levels were only marginally affected and did not significantly differ between the preischemic and postischemic hydrostatic challenge maneuvers; and (3) the leakage response was not attenuated by preapplication of a thromboxane receptor antagonist with nearly complete suppression of the initial transient hypertension (data not given). The manifold increase in Kfc values must therefore be ascribed to a dramatic increase in capillary endothelial permeability, as the microvasculature is the predominant site of lung fluid filtration, and there is no reason for assuming a manifold enlargement of the capillary filtration area in the postischemic period.
Compared with the routine approach with interruption of both perfusion and ventilation in the absence of alveolar and vascular distension, three types of "biophysical intervention" turned out to clearly affect the development of the leakage response.
Alveolar Distension
Beneficial effects of lung ventilation during preservation for
transplantation were described in early studies addressing this
subject (16) and were also noted in an isolated perfused lung model (19). Nevertheless, during current lung transplantation routine, lungs are stored in an atelectatic state or some
state of semi-inflation. Protection by ventilation may be exerted via the continuous alveolar supply with oxygen (see below) or via oxygen-independent mechanical events such as
prevention of alveolar collapse and/or cyclic "stretch" of the
alveolar structures. Our results suggest that both aspects contribute to the protective effect of lung ventilation during ischemia. The role of the mechanical impact of ventilation is supported by the finding that
most obvious for the experiments
with 180 min of ischemia
the leakage response was significantly reduced in the lungs undergoing continuous ventilation with an anoxic gas as compared with collapsed lungs or those
being statically inflated. These observations are in line with a
study in an in vivo canine model of ischemia, showing that in
the absence of O2, ventilation per se, but not static inflation,
conferred protection to the ischemic lung (13). What is the link
between ventilation-dependent, dynamic mechanical forces
and attenuation of lung injury? Previous studies showed an
impairment of surfactant function after lung transplantation
(24), which might be prevented by ongoing ventilation. Wirtz
and Dobbs (25) demonstrated that even a single stretch of alveolar type II cells is a most potent stimulus of surfactant secretion. Moreover, surfactant treatment before reperfusion
was recently demonstrated to improve the immediate function
of lung transplants in rats (26). Altogether, these data suggest
that cyclic alveolar distension might be operative via enhanced
surfactant secretion, and an integer alveolar surfactant system
has long since been implicated in the maintenance of the lung
endoepithelial barrier function (27). This reasoning does not,
of course, exclude alternative mechanisms such as stretch-related stimulation of lung parenchymal NO and prostacyclin synthesis by which anoxic ventilatory movements may be operative in
limiting the leakage response in the current I-R model.
Alveolar Oxygen Supply
Previous studies addressing the impact of alveolar oxygen supply during ischemia on the development of postischemic lung injury forwarded inconsistent results. Fisher and colleagues (14) noted more or less independence of reperfusion-associated edema formation of the alveolar oxygen tension and the type of ventilation during 90 min of ischemia in rabbit lungs. Hamvas and coworkers (13) found that a combination of alveolar hypoxia (but not hyperoxia) and absence of ventilation resulted in lung injury, which provides evidence for a protective role of alveolar oxygen. Beneficial effects of oxygen were also noted in a recent study using nonperfused rat cadaver lungs, showing that O2 ventilation preserved adenine nucleotides, which was correlated with increased pulmonary parenchymal cell viability (28). Akashi and colleagues (29) observed attenuation of ischemic rat lung injury by inflation with room air as compared with inflation with nitrogen. On the other hand, the presence of alveolar oxygen during ischemia resulted in enhanced lung injury upon reperfusion in isolated rat (10, 12) and dog lungs (11), which was ascribed to the generation of oxygen radicals during ischemia. The reasons for these apparently inconsistent results are not clear, but they were related to the dual role of oxygen, being metabolic substrate, on the one hand, and enhancing oxygen radical formation, on the other hand. In none of these studies was a possible role of vascular distension during ischemia appreciated. Interestingly, in the lungs undergoing ischemia without maintaining a positive intravascular pressure in the current study, no significant protective effect of alveolar oxygen was noted. In contrast, a mitigation of postischemic injury was observed in normoxic and even in hyperoxic ventilated lungs as compared with anoxic ventilated organs when a positive intravascular pressure was maintained. It is conceivable that under conditions of vascular distension instead of vascular collapse, oxygen provided via the alveolar space may be more easily distributed to sites not located in the vicinity of the alveolar compartment, enhanced by ventilation-induced cyclic changes of local intravascular volume and thus some limited kind of regional flow. Such a mechanism might help to maintain the metabolic function of pulmonary cells, thereby overriding putative negative effects of enhanced oxygen radical formation.
Vascular Distension
The most impressive finding of the present study was the
marked protective effect of maintaining a positive intravascular pressure on the development of postischemic lung injury.
In IP
lungs, regardless of the presence or absence of alveolar
oxygen supply, 120 min of warm ischemia resulted in immediate, severe capillary leakage, whereas even 240 min of ischemia
caused only a moderate leakage response in normoxic ventilated
lungs in which a positive intravascular pressure was maintained
throughout the ischemic period. Several mechanisms may be
considered to underly this notable finding.
(1) Prevention of vascular collapse and reopening phenomena. Because the lungs were perfused in an upright position
with arterial and venous pressures referenced at the hilus, an
intravascular pressure of zero would result in collapsed vasculature in large parts of the lung. This may result in physical
contact of opposing endothelial surfaces, demanding an initial
pressure step to overcome the vessel occlusion, and possibly
contributing to endothelial injury in the postischemic lungs. In
line with this reasoning, the initial transient hypertension was
higher in the IP
than in the IP+ lungs. However, this pressure
peak is still largely suppressed by a thromboxane receptor
antagonist (data not given), suggesting thromboxane-related
vasoconstriction rather than "physical" vessel occlusion as the
main underlying event of the initial Ppa elevation.
(2) Dampening of neutrophil-related inflammatory events. The lung microvasculature is known to harbor a large number of neutrophils: even under conditions of prolonged ex vivo buffer perfusion, this is as large as 1.6-fold of the respective circulating leukocyte population in rabbits, as suggested by morphometric studies (30). Neutrophils have long been implicated in the pathogenesis of postischemic lung injury (31, 32). At reduced vessel diameters caused by (partial) collapse of the lung vasculature, neutrophil-endothelial interactions and related injury might be intensified.
(3) Sealing. Hydrostatic forces acting on endothelial cells
strongly affect their permeability characteristics. In a previous study concerned with porcine pulmonary artery endothelial
monolayers from our group, the establishment of a positive
baseline hydrostatic pressure resulted in a marked reduction
of hydraulic conductivity, alongside an increase in the albumin
reflection coefficient, a phenomenon called "sealing" (20). Reorganization of endothelial stress fibers has been suggested to
contribute to this process of sealing, but the underlying events
are still not fully elucidated. Although there is hitherto no proof
that this phenomenon is also operative under in vivo conditions, it is tempting to speculate that such a mechanism of endothelial sealing might contribute to the marked differences in
the leakage response between IP
and IP+ lungs.
(4) Shear-stress-induced mediator release. Becker and colleagues (33) observed protective effects of maintained intravascular volume on injury in ischemic (not reperfused) ventilated ferret lungs, which were prevented by L-NAME likely through blocking nitric oxide generation (34). These observations may favor a protective role of vascular distension-evoked NO synthesis; however, a corresponding increase in cyclic nucleotide levels was recently reported to be missed (35). A detailed analysis of the impact of vascular distension on ischemia- and reperfusion-related vasoactive mediator generation is hitherto not available.
In conclusion, the present study has demonstrated the importance of biophysical factors for the severity of pulmonary ischemia-reperfusion injury. Vascular distension by maintenance of a low positive intravascular pressure during lung ischemia was identified as a powerful strategy for decreasing the leakage response and associated lung edema formation in the postischemic period. This protective effect was further enhanced by continued ventilation as well as supplementation of alveolar oxygen during lung ischemia. These results may have important implications for organ preservation in lung transplantation. Further elucidation of the mechanisms involved in the protection conferred by vascular distension will be a goal of future investigations.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Hartwig Schütte, Department of Internal Medicine, Justus-Liebig University, Klinikstrasse 36, 35385 Giessen, Germany.
(Received in original form June 10, 1997 and in revised form August 7, 1997).
Acknowledgments: Supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 547 "Kardiopulmonales Gefäßsystem."
| |
References |
|---|
|
|
|---|
1. Sleiman, C., H. Mal, M. Fournier, J. P. Duchatelle, P. Icard, O. Groussard, G. Jebrak, J. L. Mollo, O. Raffy, C. Roue, M. Kitzis, B. Andreassian, and R. Pariente. 1995. Pulmonary reimplantation response in single lung transplantation. Eur. Respir. J. 8: 5-9 [Abstract].
2. Levinson, R. M., D. Shure, and K. M. Moser. 1986. Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am. Rev. Respir. Dis. 134: 1241-1245 [Medline].
3.
Matsuura, Y.,
T. Nomimura,
H. Murakami,
T. Matsushima,
M. Kakehashi, and
H. Kajihara.
1991.
Clinical analysis of reexpansion pulmonary edema.
Chest
100:
1562-1566
4. Ward, B. J., and D. B. Pearse. 1988. Reperfusion pulmonary edema after thrombolytic therapy of massive pulmonary embolism. Am. Rev. Respir. Dis. 138: 1308-1311 [Medline].
5. Ljungman, A. G., C. Grum, G. M. Deeb, S. F. Bolling, and M. L. Morganroth. 1991. Inhibition of cyclooxygenase production attenuates ischemia-reperfusion injury. Am. Rev. Respir. Dis. 143: 610-617 [Medline].
6.
Hsu, K.,
D. Wang,
S.-Y. Wu,
C.-Y. Shen, and
H. I. Chen.
1994.
Ischemia-reperfusion lung injury attenuated by ATP-MgCl2 in rats.
J. Appl.
Physiol.
76:
545-552
7.
Wickersham, N. E.,
J. E. Johnson,
B. O. Meyrick,
R. J. Gilroy, and
J. E. Loyd.
1991.
Lung ischemia-reperfusion in awake sheep: protection
with verapamil.
J. Appl. Physiol.
71:
1554-1562
8.
Hamvas, A.,
R. Palazzo,
L. Kaiser,
J. Cooper,
T. Shuman,
M. Velazquez,
B. Freeman, and
D. P. Schuster.
1992.
Inflammation and oxygen free
radical formation during pulmonary ischemia-reperfusion injury.
J.
Appl. Physiol.
72:
621-628
9.
Palazzo, R.,
A. Hamvas,
T. Shuman,
L. Kaiser,
J. Cooper, and
D. P. Schuster.
1992.
Injury in nonischemic lung after unilateral pulmonary
ischemia with reperfusion.
J. Appl. Physiol.
72:
612-620
10.
Eckenhoff, R. G.,
C. Dodia,
Z. Tan, and
A. B. Fisher.
1992.
Oxygen-
dependent reperfusion injury in the isolated rat lung.
J. Appl. Physiol.
72:
1454-1460
11.
Koyama, I.,
T. J. K. Toung,
M. C. Rogers,
G. H. Gurtner, and
R. T. Traystman.
1987.
O2 radicals mediate reperfusion lung injury in ischemic O2-ventilated canine pulmonary lobe.
J. Appl. Physiol.
63:
111-115
12. Ayene, S., C. Dodia, and A. B. Fisher. 1992. Role of oxygen in oxidation of lipid and protein during ischemia/reperfusion in isolated perfused rat lung. Arch. Biochem. Biophys. 296: 183-189 [Medline].
13.
Hamvas, A.,
C. K. Park,
R. Palazzo,
M. Liptay,
J. Cooper, and
D. P. Schuster.
1992.
Modifying pulmonary ischemia-reperfusion injury by
altering ventilatory strategies during ischemia.
J. Appl. Physiol.
73:
2112-2119
14.
Fisher, P. W.,
Y.-C. T. Huang,
T. P. Kennedy, and
C. A. Piantadosi.
1993.
PO2-dependent hydroxyl radical production during ischemia-reperfusion lung injury.
Am. J. Physiol.
265:
L279-L285
15. Okuda, M., K. Furuhashi, Y. Nakai, and M. Muneyuki. 1993. Decrease of ischemia-reperfusion related lung oedema by continuous ventilation and allopurinol in rat perfusion model. Scand. J. Clin. Lab. Invest. 53: 625-631 [Medline].
16. Veith, F. J., S. B. Sinha, J. S. Graves, S. J. Boley, and J. C. Dougherty. 1971. Ischemic tolerance of the lung: the effect of ventilation and inflation. J. Thorac. Cardiovasc. Surg. 61: 804-810 [Medline].
17. Stevens, G. H., M. M. Sanchez, and G. L. Chappell. 1973. Enhancement of lung preservation by prevention of lung collapse. J. Surg. Res. 14: 400-405 [Medline].
18. Fonkalsrud, E. W., M. Sanchez, L. Lassaletta, C. Smeesters, and I. Higashijima. 1975. Extended preservation of the ischemic canine lung by ventilation with PEEP. J. Surg. Res. 18: 437-445 [Medline].
19. Badellino, M. M., M. L. Moragnroth, C. M. Grum, M. J. Lynch, S. F. Bolling, and G. M. Deeb. 1989. Hypothermia or continuous ventilation decreases ischemia-reperfusion injury in an ex vivo lung model. Surgery 105: 752-760 [Medline].
20.
Suttorp, N.,
T. Hessz,
W. Seeger,
A. Wilke,
R. Koob,
F. Lutz, and
D. Drenckhahn.
1988.
Bacterial exotoxins and endothelial permeability
for water and albumin in vitro.
Am. J. Physiol.
255:
C368-C376
21. Seeger, W., D. Walmrath, F. Grimminger, S. Rosseau, H. Schütte, H. J. Krämer, L. Ermert, and L. Kiss. 1994. Adult respiratory distress syndrome: model systems using isolated perfused rabbit lungs. Methods Enzymol. 233: 549-584 [Medline].
22.
Seeger, W.,
D. Walmrath,
M. Menger, and
H. Neuhof.
1986.
Increased lung vascular permeability after arachidonic acid and hydrostatic challenge.
J. Appl. Physiol.
61:
1781-1788
23.
Zamora, C. A.,
D. A. Baron, and
J. E. Hefner.
1993.
Thromboxane contributes to pulmonary hypertension in ischemia-reperfusion lung injury.
J. Appl. Physiol.
74:
224-229
24. Veldhuizen, R. A. W., J. Lee, D. Sandler, W. Hull, J. A. Whitsett, J. Lewis, F. Possmayer, and R. Novick. 1993. Alterations in pulmonary surfactant composition and activity after experimental lung transplantation. Am. Rev. Respir. Dis. 148: 208-215 [Medline].
25.
Wirtz, H. R., and
L. G. Dobbs.
1990.
Calcium mobilization and exocytosis after one mechanical stretch of lung epithelial cells.
Science
250:
1266-1269
26. Erasmus, M. E., A. H. Petersen, G. Hofstede, H. P. Haagsman, S. Bambang, Oetomo, and J. Prop. 1996. Surfactant treatment before reperfusion improves the immediate function of lung transplants in rats. Am. J. Respir. Crit. Care Med. 53: 665-670 .
27.
Evander, E.,
P. Wollmer,
S. Valind,
L. Sörnmo,
J. John, and
B. Jonson.
1994.
Biexponential pulmonary clearance of 99mTc-DTPA induced by
detergent aerosol.
J. Appl. Physiol.
77:
190-196
28. Darmini, A. M., E. J. Tom, C. S. Roberts, D. C. Henke, J. J. Lemasters, and T. M. Egan. 1995. When does the lung die: time course of high energy phosphate depletion and relationship to lung viability after death. J. Surg. Res. 59: 468-474 [Medline].
29. Akashi, A., K. Nakahara, W. Kamiike, A. Matsumura, N. Hatanaka, Y. Kawashima, Y. Yoshida, and K. Tagawa. 1993. Attenuation of warm ischemic injury of rat lung by inflation with room air: assessment of cellular components and the surfactant in the bronchoalveolar lavage fluid in relation to changes in cellular adenosine triphosphate. Transplantation 55: 24-30 [Medline].
30.
Ermert, L.,
H. R. Duncker,
S. Rosseau,
H. Schütte, and
W. Seeger.
1994.
Morphometric analysis of pulmonary intracapillary leukocyte pools in
ex vivo-perfused rabbit lungs.
Am. J. Physiol.
267:
L64-L70
31.
Adkins, W. K., and
A. E. Taylor.
1990.
Role of xanthine oxidase and
neutrophils in ischemia-reperfusion injury in rabbit lung.
J. Appl. Physiol.
69:
2012-2018
32. Seibert, A. F., J. Haynes, and A. Taylor. 1993. Ischemia-reperfusion injury in the isolated rat lung: role of flow and endogenous leukocytes. Am. Rev. Respir. Dis. 147: 270-275 [Medline].
33.
Becker, P. M.,
D. B. Pearse, and
J. T. Sylvester.
1993.
Effects of oxygen tension and glucose concentration on ischemic injury in ventilated ferret lungs.
J. Appl. Physiol.
75:
1233-1237
34. Becker, P. M., W. L. Buchanan, and J. T. Sylvester. 1995. Protective effects of intravascular volume on ischemic injury of ventilated ferret lungs (abstract). Am. J. Respir. Crit. Care Med. 151: A759 .
35. Becker, P. M., W. L. Buchanan, T. W. Privett, and D. B. Pearse. 1997. Effects of ischemia on cyclic nucleotide levels and vascular permeability (abstract). Am. J. Respir. Crit. Care Med. 155: A834 .
This article has been cited by other articles:
![]() |
Y.-W. Chen, K. C. Hwang, C.-C. Yen, and Y.-L. Lai Fullerene derivatives protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R21 - R26. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dodd-o, L. E. Welsh, J. D. Salazar, P. L. Walinsky, E. A. Peck, J. G. Shake, D. J. Caparrelli, B. T. Bethea, S. M. Cattaneo, W. A. Baumgartner, et al. Effect of bronchial artery blood flow on cardiopulmonary bypass-induced lung injury Am J Physiol Heart Circ Physiol, February 1, 2004; 286(2): H693 - H700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Dodd-o, M. L. Hristopoulos, N. Faraday, and D. B. Pearse Effect of ischemia and reperfusion without airway occlusion on vascular barrier function in the in vivo mouse lung J Appl Physiol, November 1, 2003; 95(5): 1971 - 1978. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. SCHUTTE, K. MAYER, H. BURGER, M. WITZENRATH, T. GESSLER, W. SEEGER, and F. GRIMMINGER Endogenous Nitric Oxide Synthesis and Vascular Leakage in Ischemic-Reperfused Rabbit Lungs Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 412 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Pearse and P. M. Becker Effect of time and vascular pressure on permeability and cyclic nucleotides in ischemic lungs Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2077 - H2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Schutte, M. Witzenrath, K. Mayer, N. Weissmann, A. Schell, S. Rosseau, W. Seeger, and F. Grimminger The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs Am J Physiol Lung Cell Mol Physiol, September 1, 2000; 279(3): L496 - L502. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. HERMLE, H. SCHÜTTE, D. WALMRATH, K. GEIGER, W. SEEGER, and F. GRIMMINGER Ventilation-Perfusion Mismatch after Lung Ischemia-Reperfusion . Protective Effect of Nitric Oxide Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1179 - 1187. [Abstract] [Full Text] |
||||
![]() |
D. B. Pearse, E. M. Wagner, and S. Permutt Effect of ventilation on vascular permeability and cyclic nucleotide concentrations in ischemic sheep lungs J Appl Physiol, January 1, 1999; 86(1): 123 - 132. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |